Eli Lilly Reports Strong Results; Investors Still Worried about Future

Eli Lilly & Co. (LLY), the pharmaceutical company behind antidepressant drug Prozac and erectile dysfunction treatment Cialis, reported strong sales in the fourth quarter, as expected. The company swung to a profit of $915.4 million, or 83 cents per share. That compared with a loss of $3.63 billion, or $3.31 per share, in the same period last year on charges related to its ImClone acquisition.Excluding special items, Lilly earned 91 cents share, inline with analyst estimates.